Type 1 Diabetes Trial, Recruiting (NCT06453928)

Type 1 Diabetes Trial, Recruiting NCT06453928 Sponsor: University of California, Los Angeles Condition: Type 1 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT06453928 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 1 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have Type 1 Diabetes
People whose most recent A1c blood sugar level is above 8.5%
People who do not currently use an insulin pump
People whose primary language is English or Spanish
People who have medical insurance coverage

Who may not be able to join:

People who have not had an A1c blood test recorded in the past year
People who have certain other health conditions that can cause A1c test results to be inaccurate (confirm with trial site)
People who have cognitive, physical, or mental health challenges that would make it difficult to use diabetes management technology
People with a life expectancy of less than one year
People who are currently pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 310-267-0625

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06453928

Sponsor: University of California, Los Angeles

Phase: Not Applicable

Status: Recruiting

Condition: Type 1 Diabetes

Trial contact: 310-267-0625

More information: https://clinicaltrials.gov/study/NCT06453928

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have Type 1 Diabetes
People whose most recent A1c blood sugar level is above 8.5%
People who do not currently use an insulin pump
People whose primary language is English or Spanish
People who have medical insurance coverage

Who may not be able to join:

People who have not had an A1c blood test recorded in the past year
People who have certain other health conditions that can cause A1c test results to be inaccurate (confirm with trial site)
People who have cognitive, physical, or mental health challenges that would make it difficult to use diabetes management technology
People with a life expectancy of less than one year
People who are currently pregnant

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of California, Los Angeles

Registry

ClinicalTrials.gov

Start date

5 September 2024

Est. completion

31 January 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Proportion of screened participants that are eligible; Proportion of enrolled participants that are randomized; Proportion of average time delay to enrollment; Proportion of retention among participants randomized to the Intervention Group; Proportion of retention among participants randomized; Proportion of retention among participants randomized; Number of participants who adhere to assigned treatment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov